Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM5A | P29375 | 3/20 | 0.44 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.44 |
| ▸ | KDM4A | O75164 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23926395 | 0.98 | KDM5A (0.42) | KDM5APHF8KDM2AKDM4CKDM4A | |
| SCHEMBL4448884 | 0.94 | KDM5A (0.50) | KDM5APHF8KDM2AKDM4CKDM4A | |
| SCHEMBL7591133 | 0.93 | KDM5A (0.53) | KDM5APHF8KDM2AKDM4CKDM4A | |
| SCHEMBL7590760 | 0.93 | KDM5A (0.53) | KDM5APHF8KDM2AKDM4CKDM4A | |
| SCHEMBL14245381 | 0.93 | KDM5A (0.53) | KDM5APHF8KDM2AKDM4CKDM4A | |
| SCHEMBL14245337 | 0.93 | KDM5A (0.53) | KDM5APHF8KDM2AKDM4CKDM4A | |
| SCHEMBL7594925 | 0.93 | KDM5A (0.53) | KDM5APHF8KDM2AKDM4CKDM4A | |
| SCHEMBL7594914 | 0.93 | KDM5A (0.53) | KDM5APHF8KDM2AKDM4CKDM4A | |
| SCHEMBL1770283 | 0.88 | HPGD (0.48) | KDM5APHF8KDM2AKDM4CKDM4A | |
| SCHEMBL464871 | 0.88 | HPGD (0.48) | KDM5APHF8KDM2AKDM4CKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12460032-B2 | Compositions with high refractive index and Abbe number | Johnson & Johnson Surgical Vision, Inc. (US) | 2025-11-04 | — | — | US | claimed |
| US-20240218102-A1 | COMPOSITIONS WITH HIGH REFRACTIVE INDEX AND ABBE NUMBER | Johnson & Johnson Surgical Vision, Inc. | 2024-07-04 | — | — | US | claimed |
| EP-3962411-A1 | HIGH REACTIVE INDEX, HIGH ABBE COMPOSITIONS | Johnson & Johnson Surgical Vision, Inc. (US) | 2022-03-09 | — | — | EP | claimed |
| EP-3634508-B1 | HIGH REFRACTIVE INDEX, HIGH ABBE NUMBER INTRAOCULAR LENS MATERIALS | ALCON INC (CH) | 2021-10-27 | — | — | EP | claimed |
| WO-2020225686-A1 | HIGH REACTIVE INDEX, HIGH ABBE COMPOSITIONS | Johnson & Johnson Surgical Vision, Inc. (US) | 2020-11-12 | — | — | WO | claimed |
| EP-4720729-A1 | SINGLE PIECE INTRAOCULAR LENS WITH INTEGRALLY COUPLED HAPTICS | Johnson & Johnson Surgical Vision, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260028439-A1 | COMPOSITIONS WITH HIGH REFRACTIVE INDEX AND ABBE NUMBER | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12460032-B2 | Compositions with high refractive index and Abbe number | Johnson & Johnson Surgical Vision, Inc. (US) | 2025-11-04 | — | — | US | disclosed |
| US-20240384021-A1 | HIGH REFRACTIVE INDEX, HIGH ABBE COMPOSITIONS | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2024-11-21 | — | — | US | disclosed |
| US-12071497-B2 | High refractive index, high Abbe compositions | Johnson & Johnson Surgical Vision, Inc. (US) | 2024-08-27 | — | — | US | disclosed |
| US-20240218102-A1 | COMPOSITIONS WITH HIGH REFRACTIVE INDEX AND ABBE NUMBER | Johnson & Johnson Surgical Vision, Inc. | 2024-07-04 | — | — | US | disclosed |
| US-11958923-B2 | Compositions with high refractive index and abbe number | Johnson & Johnson Surgical Vision, Inc. (US) | 2024-04-16 | — | — | US | disclosed |
| US-7417090-B2 | Water-dispersible polyisocyanate composition, production thereof, and water-based curable composition and application thereof | DAINIPPON INK & CHEMICALS, INC. (JP) | 2008-08-26 | — | — | US | disclosed |
| EP-1455739-B1 | COSMETIC AGENT CONTAINING AT LEAST ONE COPOLYMER HAVING N-VINYLLACTAM UNITS | BASF AG (DE) | 2007-11-28 | — | — | EP | disclosed |
| US-20070049691-A1 | Water-dispersible polyisocyanate composition, production thereof, and water-based curable composition and application thereof | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-03-01 | — | — | US | disclosed |
| EP-0876252-B1 | USE OF POLYMERS BASED ON ETHYLENE, (METH)ACRYLIC ACID ESTERS AND (METH)ACRYLIC ACID FOR SEALING PANES OF LAMINATED SAFETY GLASS | BASF AG (DE) | 2002-10-16 | — | — | EP | disclosed |
| EP-0580045-A1 | Compatible polymer mixtures from copolycarbomates and methycrylate copolymers | Röhm GmbH (DE) | 1994-01-26 | — | — | EP | disclosed |
| EP-0580046-A1 | UV-absorbing coating layers for copolycarbonates | Röhm GmbH (DE) | 1994-01-26 | — | — | EP | disclosed |
| EP-0171755-B1 | VINYL-CARBOXYLIC-ACID ESTERS | RÖHM GMBH (DE) | 1988-05-25 | — | — | EP | disclosed |
| EP-0171755-A1 | Vinyl-carboxylic-acid esters | RÖHM GMBH (DE) | 1986-02-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028439-A1 | COMPOSITIONS WITH HIGH REFRACTIVE INDEX AND ABBE NUMBER | SMCHD1, MACF1, LAGE3 | KDM5A 3093/4885PHF8 2531/4885KDM2A 2411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.